Insys Therapeutics New (INSY) Holder Gsa Capital Partners Llp Has Trimmed Position by $319200; Tnb Financial Has …

<!–

Stock News

–>

August 19, 2018 – By Mary Kidd

CVS Health Corporation (NYSE:CVS) Logo

Gsa Capital Partners Llp decreased its stake in Insys Therapeutics Inc New (INSY) by 79.17% based on its latest 2018Q1 regulatory filing with the SEC. Gsa Capital Partners Llp sold 53,200 shares as the company’s stock declined 15.10% with the market. The hedge fund held 14,000 shares of the health care company at the end of 2018Q1, valued at $85,000, down from 67,200 at the end of the previous reported quarter. Gsa Capital Partners Llp who had been investing in Insys Therapeutics Inc New for a number of months, seems to be less bullish one the $573.76M market cap company. The stock increased 0.13% or $0.01 during the last trading session, reaching $7.73. About 208,053 shares traded. INSYS Therapeutics, Inc. (NASDAQ:INSY) has declined 47.95%

... read more at: https://cardinalweekly.com/insys-therapeutics-new-insy-holder-gsa-capital-partners-llp-has-trimmed-position-by-319200-tnb-financial-has-lifted-stake-in-cvs-health-cvs/

by